Atrium Therapeutics
RNA
#4336
Rank
A$3.47 B
Marketcap
A$22.04
Share price
-6.47%
Change (1 day)
-52.74%
Change (1 year)

Atrium Therapeutics (RNA) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : A$0.10 Billion

According to Atrium Therapeutics's latest financial reports the company's total liabilities are A$0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Atrium Therapeutics - Total liabilities on balance sheet (from 2024 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.10 B-3.37%
2024-12-31A$0.10 B-7.55%
2023-12-31A$0.11 B